Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Ophthalmology

Understanding Your Diagnosis: Cytomegalovirus Retinitis Overview & Red Flags

At a Glance

CMV retinitis can silently damage the retina in people with severely weakened immune systems, especially advanced HIV or transplant recipients. New floaters, flashes, shadows, blurred vision, or blind spots require same-day eye evaluation because early antiviral treatment can protect vision.

It is natural to feel a deep sense of fear when you are told a virus could threaten your sight. Cytomegalovirus (CMV) retinitis is a serious viral infection of the retina, the light-sensitive layer at the back of the eye that sends images to your brain [1][2]. For most people with healthy immune systems, CMV is a harmless virus that the body keeps in check [1]. However, when the immune system is severely weakened, the virus can “reactivate” and begin to destroy retinal cells, causing retinal necrosis (tissue death) [1][2].

If you are reading this, it is likely because you or a loved one is in a high-risk group. Understanding why this happens and knowing the “red flag” symptoms can help you act quickly to protect your vision.

Who is at Risk?

CMV retinitis is strongly associated with states where the immune system’s “cellular defense” (specifically T-cells) is no longer able to control the virus [1]. This typically happens in two main groups:

  • People with Advanced HIV/AIDS: The risk is highest when the CD4 count (a measure of immune strength) drops below 50 cells/µL [3][4]. This is a risk indicator, not an absolute rule. Doctors generally recommend baseline and serial dilated examinations at CD4 counts below 50 until the immune system recovers above 100 for a required period [3][4].
  • Transplant Recipients: Patients who have received a hematopoietic stem cell transplant (HSCT or bone marrow transplant) or a solid organ transplant (such as a kidney or liver) are at risk due to the medications used to prevent organ rejection [5][6]. Risk depends on CMV serostatus, transplant type, prophylaxis, and the degree of immunosuppression [5][6][7].

While blood tests can show if the virus is active in your body, they cannot always tell if it is in your eyes. It is possible to have CMV retinitis even if the virus is not found in your blood at that moment [8][9].

Why You Might Not Have Symptoms

One of the most dangerous aspects of CMV retinitis is that it can be “silent” in its early stages [10]. You may not feel any pain, and your vision may seem perfectly clear [10][11]. This happens for two reasons:

  1. Peripheral Start: The infection often starts at the edges (periphery) of your retina [2][12]. Since you use the center of your retina for reading and seeing faces, you might not notice the damage happening at the sides.
  2. Low Inflammation: Because your immune system is weak, your eye may not become red or painful (inflamed) the way it would with a typical infection [10].

Because of this, regular screening exams are vital for high-risk patients, even if you feel fine. In some studies, up to 71% of patients with CMV retinitis had no symptoms when they were first diagnosed during a routine check-up [13]. During a dilated exam, you will receive eye drops to enlarge your pupils. Expect temporary blurred vision and light sensitivity; you should arrange for transportation home.

Emergency Red Flags

If you experience any of the following symptoms, you must contact an ophthalmologist (eye surgeon) or a retina specialist for an urgent, same-day evaluation. Do not wait for your next scheduled appointment. If a specialist is unavailable, go to an emergency department and explicitly identify yourself as immunocompromised with CMV retinitis.

  • New Floaters: These may look like tiny “cobwebs,” strings, or dark spots drifting across your field of vision [2][12].
  • Flashing Lights: Sudden bursts or streaks of light, similar to a camera flash, often seen in your side vision [14][15].
  • A “Curtain” or “Shadow”: The feeling that a dark veil or shadow is moving across your vision or blocking a portion of it [14]. This can be a sign of retinal detachment, a surgical emergency [16][17].
  • Blurred or Dimmed Vision: A sudden or gradual “fuzziness” or loss of sharpness in one or both eyes [2][12].
  • Blind Spots: Missing areas or “holes” in your visual field [14].

The Risks of Delay

CMV retinitis is a progressive disease. Without treatment, it will continue to spread toward the center of the retina (the macula) and the optic nerve [2][18]. If the virus reaches these areas, vision loss can be sudden, profound, and often permanent [19][20].

Furthermore, the infected retina becomes thin and fragile, which can lead to a rhegmatogenous retinal detachment—where the retina pulls away from the back of the eye [16][17]. Early treatment with antiviral medications is the most effective way to stop this progression and save your sight [18][21].

Term Definition
Retina The “film” at the back of the eye that captures light.
Viremia When a virus (like CMV) is present and circulating in the bloodstream.
Dilated Exam An eye exam where drops are used to enlarge the pupil, allowing the doctor to see the entire retina.
Necrosis The death of cells or tissues, in this case caused by the virus.
Immune Recovery When your immune system begins to get stronger (e.g., after starting HIV medications or reducing transplant drugs).

By staying vigilant and attending all scheduled eye screenings, you are taking the most important steps toward protecting your vision. If you are in a high-risk group, ensure your eye doctor is aware of your CD4 count or transplant status [22][23].

Common questions in this guide

What is CMV retinitis, and why can it threaten vision?
CMV retinitis is an infection of the retina caused by cytomegalovirus. When the immune system is severely weakened, the infection can destroy retinal tissue and spread toward the center of vision or the optic nerve, causing permanent vision loss if treatment is delayed.
Who is most at risk for CMV retinitis?
The highest-risk groups include people with advanced HIV/AIDS, especially when the CD4 count is below 50 cells/µL, and people who have had a hematopoietic stem cell or solid organ transplant. Transplant medications that suppress the immune system and other forms of severe immune weakness increase risk.
Can CMV retinitis be present without symptoms or a positive blood test?
Yes. CMV retinitis may begin in the peripheral retina, where damage is harder to notice, and weakened immune defenses may cause little eye inflammation or pain. A blood test may show CMV activity but cannot always confirm whether the virus is affecting the eye.
Which vision changes require urgent evaluation for CMV retinitis?
New floaters, flashing lights, a curtain or shadow across your vision, sudden blurring or dimming, and blind spots require same-day evaluation. Contact an ophthalmologist or retina specialist immediately; if one is unavailable, go to an emergency department and explain that you are immunocompromised and have or may have CMV retinitis.
Why are regular dilated eye exams important if I feel fine?
A dilated eye exam lets the doctor view the entire retina, including areas at the edges where CMV retinitis may start. High-risk people may need baseline and repeat examinations even without symptoms, because early disease can be silent.
How is CMV retinitis treated, and what can happen if treatment is delayed?
Doctors use antiviral medication to stop the infection from spreading and may coordinate HIV treatment or changes to transplant medicines to support immune recovery. Untreated infection can reach the macula or optic nerve, cause severe permanent vision loss, or weaken the retina enough to lead to retinal detachment, which may require surgery.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my most recent CD4 count, and how does that affect my risk for CMV retinitis?
  2. 2.Since I have recently had a high CMV viral load in my blood, how often should I have a dilated eye exam?
  3. 3.Are the changes you see in my eye in the 'periphery' (edges) or near the 'macula' (center) or 'optic nerve'?
  4. 4.If I start antiviral treatment today, what is the realistic expectation for my vision, and what side effects should we monitor in my blood work?
  5. 5.Do I have signs of a 'retinal detachment' or 'retinal necrosis' that require immediate surgery?
  6. 6.How will my HIV or transplant medications be adjusted to help my immune system fight this virus while I am on antivirals?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion.

    Gupta MP, Coombs P, Prockop SE, et al.

    Ophthalmic surgery, lasers & imaging retina 2015; (46(1)):80-2 doi:10.3928/23258160-20150101-14.

    PMID: 25559515
  2. 2

    Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment.

    Zhang J, Kamoi K, Zong Y, et al.

    Viruses 2024; (16(9)) doi:10.3390/v16091427.

    PMID: 39339903
  3. 3

    HIV-induced Retinitis.

    Wons J, Kempen J, Garweg JG

    Ocular immunology and inflammation 2020; (28(8)):1259-1268 doi:10.1080/09273948.2020.1808225.

    PMID: 32966142
  4. 4

    Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare.

    Leenasirimakul P, Liu Y, Jirawison C, et al.

    The British journal of ophthalmology 2016; (100(8)):1017-21 doi:10.1136/bjophthalmol-2016-308556.

    PMID: 27297217
  5. 5

    Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.

    Kim T, Lee YM, Lee SO, et al.

    The Korean journal of internal medicine 2016; (31(5)):961-70 doi:10.3904/kjim.2015.079.

    PMID: 27055664
  6. 6

    The Potential Association of Delayed T Lymphocyte Reconstitution Within Six Months Post-Transplantation With the Risk of Cytomegalovirus Retinitis in Severe Aplastic Anemia Recipients.

    Mo W, Chen X, Zhang X, et al.

    Frontiers in cellular and infection microbiology 2022; (12()):900154 doi:10.3389/fcimb.2022.900154.

    PMID: 35694535
  7. 7

    A case series: cytomegalovirus retinitis following autologous hematopoietic cell transplantation: a call for early detection and aggressive management.

    Zhou Y, Liu M, Zhang J, et al.

    Frontiers in medicine 2025; (12()):1693928 doi:10.3389/fmed.2025.1693928.

    PMID: 41179870
  8. 8

    High Blood Cytomegalovirus Load Suggests Cytomegalovirus Retinitis in HIV/AIDS Patients: A Cross-Sectional Study.

    Du KF, Huang XJ, Chen C, et al.

    Ocular immunology and inflammation 2022; (30(7-8)):1559-1563 doi:10.1080/09273948.2021.1905857.

    PMID: 34125650
  9. 9

    [Relationship between opacity of cytomegalovirus retinitis lesion borders and aqueous viral load among patients after allogeneic hematopoietic stem cell transplantation].

    Lu Y, Hong J, Li HP, et al.

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2022; (58(12)):1033-1038 doi:10.3760/cma.j.cn112142-20220218-00062.

    PMID: 36480884
  10. 10

    Cytomegalovirus retinitis in hospitalized people living with HIV in the late antiretroviral therapy era in São Paulo, Brazil.

    Bogoni G, Lucas Júnior RM, Reis Schneider GA, et al.

    International journal of STD & AIDS 2023; (34(1)):48-53 doi:10.1177/09564624221135294.

    PMID: 36259434
  11. 11

    Seeing the Bigger Picture: Cytomegalovirus Retinitis Screening in Pediatric Hematopoietic Stem Cell Transplant Patients.

    Lind KT, DeSmith K, Marks B, et al.

    Pediatric blood & cancer 2025; (72(10)):e31910 doi:10.1002/pbc.31910.

    PMID: 40682285
  12. 12

    "For your eyes only": ophthalmic complications following lung transplantation.

    Dhal U, Raju S, Singh AD, Mehta AC

    Journal of thoracic disease 2018; (10(11)):6285-6297 doi:10.21037/jtd.2018.09.156.

    PMID: 30622804
  13. 13

    Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL.

    Nishijima T, Yashiro S, Teruya K, et al.

    PloS one 2015; (10(9)):e0136747 doi:10.1371/journal.pone.0136747.

    PMID: 26375282
  14. 14

    Cytomegalovirus Retinitis Complicated With Rhegmatogenous Retinal Detachment in a Non-HIV Patient With Pure Red Cell Aplasia.

    Tan CM, Noram MS

    Cureus 2025; (17(9)):e92998 doi:10.7759/cureus.92998.

    PMID: 41141209
  15. 15

    COMPARISON OF VISUAL PROGNOSIS AND CLINICAL FEATURES OF CYTOMEGALOVIRUS RETINITIS IN HIV AND NON-HIV PATIENTS.

    Kim DY, Jo J, Joe SG, et al.

    Retina (Philadelphia, Pa.) 2017; (37(2)):376-381 doi:10.1097/IAE.0000000000001144.

    PMID: 28118285
  16. 16

    Bilateral Cytomegalovirus Retinitis in a Patient with Systemic Lupus Erythematosus.

    Haze M, Kobayashi T, Kakurai K, et al.

    Case reports in ophthalmology 2016; (7(2)):303-8 doi:10.1159/000446391.

    PMID: 27462259
  17. 17

    Retinal detachment and mortality in patients with cytomegalovirus retinitis: A multicenter study in taiwan.

    Wu PY, Kang EY, Chen WD, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025; (263(2)):393-403 doi:10.1007/s00417-024-06651-2.

    PMID: 39422751
  18. 18

    Spectrum of Newly Diagnosed Cytomegalovirus Retinitis in a Developing Country in the HAART Era.

    Singh SR, Dogra M, Kaur S, et al.

    Ocular immunology and inflammation 2020; (28(1)):119-125 doi:10.1080/09273948.2018.1538460.

    PMID: 30395753
  19. 19

    Atypical cytomegalovirus retinitis in non-Hodgkin's lymphoma.

    Tyagi M, Ambiya V, Mathai A, Narayanan R

    BMJ case reports 2015; (2015()).

    PMID: 26240105
  20. 20

    Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis.

    Iu LP, Fan MC, Lau JK, et al.

    American journal of ophthalmology 2016; (165()):145-53.

    PMID: 27005706
  21. 21

    Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa.

    Hassan-Moosa R, Chinappa T, Jeena L, et al.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2017; (107(10)):843-846 doi:10.7196/SAMJ.2017.v107i10.12740.

    PMID: 29022526
  22. 22

    Cytomegalovirus-Immune Recovery Retinitis After Initiation of Highly Active Antiretroviral Therapy: A Case Series.

    Qian Y, Wang L, Jiang J, et al.

    Frontiers in medicine 2022; (9()):807013 doi:10.3389/fmed.2022.807013.

    PMID: 35573011
  23. 23

    Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.

    Jabs DA, Van Natta ML, Holland GN, et al.

    American journal of ophthalmology 2017; (174()):23-32 doi:10.1016/j.ajo.2016.10.011.

    PMID: 27984023

This page is for informational purposes only and does not constitute medical advice. If you have CMV retinitis or new vision changes, contact your ophthalmologist or retina specialist for same-day evaluation.

Get notified when new evidence is published on Cytomegalovirus retinitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.